Teva Pharmaceutical Industries TEVA
NYSE TEVA
$37.19 -0.28 (-0.76%)
At close: Aug 20, 2026 · 7:11 PM UTC

Teva Pharmaceutical Industries (TEVA) Net Cash Flow Growth (1y) (2010 - 2026)

Teva Pharmaceutical Industries (TEVA) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.30 Bn 39.65 Bn 2.15 Bn -117.27%
3 Zoetis 31.45 Bn 29.77 Bn 1.05 Bn -167.84%
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -290.21%
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn 270.63%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -367.42%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn -7.60%
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn 272.00%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn 31.78%

Historic Data

Download Data
DateValue
Jun 30, 2026 -117.27%
Mar 31, 2026 112.26%
Dec 31, 2025 1,223.30%
Sep 30, 2025 -94.69%
Jun 30, 2025 168.47%
Mar 31, 2025 -1,158.02%
Dec 31, 2024 -88.67%
Sep 30, 2024 348.32%
Jun 30, 2024 -219.96%
Mar 31, 2024 80.45%
Dec 31, 2023 111.40%
Sep 30, 2023 -254.18%
Jun 30, 2023 1,686.11%
Mar 31, 2023 -687.72%
Dec 31, 2022 113.93%
Sep 30, 2022 169.72%
Jun 30, 2022 -105.16%
Mar 31, 2022 129.23%
Dec 31, 2021 -42.07%
Sep 30, 2021 39.29%